Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 6/20 | 0.41 |
| ▸ | HTR1A | P08908 | 5/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30969713 | 0.87 | CYP3A4 (0.42) | CYP3A4CYP2D6CYP2C19ADRA1AADRA1B | |
| SCHEMBL25417926 | 0.85 | TMEM97 (0.49) | CYP3A4CYP2D6CYP2C19KDM4EKMT2A | |
| SCHEMBL25188962 | 0.78 | NPC1 (0.43) | CYP3A4CYP2D6CYP2C19KDM4EKMT2A | |
| SCHEMBL9314380 | 0.77 | CHRM2 (0.42) | ADRA1AADRA1BHTR1AADRA1D | |
| SCHEMBL31273635 | 0.75 | L3MBTL1 (0.39) | CYP3A4KDM4EKMT2AL3MBTL1MAPT | |
| SCHEMBL1499224 | 0.75 | MAPT (0.52) | CYP3A4CYP2D6CYP2C19KDM4EKMT2A | |
| SCHEMBL30969743 | 0.75 | CYP3A4 (0.44) | CYP3A4CYP2D6CYP2C19KDM4EKMT2A | |
| SCHEMBL19939756 | 0.74 | CHRM2 (0.42) | ADRA1AADRA1BHTR1AADRA1D | |
| SCHEMBL28545081 | 0.74 | GRIN1 (0.54) | ADRA1AADRA1BHTR1AADRA1D | |
| SCHEMBL11664188 | 0.74 | CHRM2 (0.42) | ADRA1AADRA1BHTR1AADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426684-B1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH & CIE (CH) | 2025-09-17 | — | — | EP | claimed |
| US-20250042871-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH & CIE (CH) | 2025-02-06 | — | — | US | claimed |
| EP-4426684-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | Firmenich SA (CH) | 2024-09-11 | — | — | EP | claimed |
| WO-2023078909-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH SA (CH) | 2023-05-11 | — | — | WO | claimed |
| EP-4426684-B1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH & CIE (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-20250042871-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH & CIE (CH) | 2025-02-06 | — | — | US | disclosed |
| EP-4426684-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | Firmenich SA (CH) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023078909-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH SA (CH) | 2023-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042871-A1 | CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED RELEASE OF ACTIVE ALDEHYDES AND KETONES | PKM, PKLR, AKR1C1 | CYP3A4 553/4885CYP2D6 689/4885CYP2C19 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.